Adagio Medical Holdings reported earnings of -$ 8.40 per ADGM share on Nov 11, 2026, beating analysts' expectations by
| Report Date | Nov 11, 2026 |
|---|---|
| Forecasted EPS | -$ 7.40 |
| Earnings Per Share (Surprise) | -$ 8.40 (-$ 1.00) |
| Last Year's EPS | -$ 12.91 |
| EPS YoY Change |
Out of the last 7 earnings reporting periods, Adagio Medical Holdings beat analysts’ expectations 2 times and fell short of expectations 3 time(s). Adagio Medical Holdings reported earnings per share of -$ 8.40 in the last report falling to reach an estimated EPS of -$ 7.40 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 11, 2026 | -$ 7.40 | -$ 8.40 | -$ 19.80 | |
| Aug 11, 2026 | -$ 8.10 | -$ 9.00 | -$ 10.50 | |
| May 12, 2026 | -$ 10.80 | -$ 9.30 | -$ 15.05 | |
| Mar 27, 2026 | -$ 9.30 | -$ 6.30 | - | - |
| Nov 12, 2025 | -$ 12.90 | -$ 19.80 | - | - |
| Aug 13, 2025 | - | -$ 10.50 | - | - |
| May 15, 2025 | - | -$ 15.05 | - | - |
Adagio Medical Holdings’s stock was trading at $ 1.84 on Nov 10, 2026 a day before the last earnings report was released.Following the release of the earnings report, ADGM’s price decreased to $ 1.82 on Nov 12, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 11, 2026 | -$ 8.40 | $ 1.84 | $ 1.82 | |
| Aug 11, 2026 | -$ 9.00 | $ 22.33 | $ 20.70 | |
| May 12, 2026 | -$ 9.30 | $ 28.20 | $ 27.02 | |
| Mar 27, 2026 | -$ 6.30 | $ 37.20 | $ 32.40 | |
| Nov 12, 2025 | -$ 19.80 | $ 26.17 | $ 24.47 | |
| Aug 13, 2025 | -$ 10.50 | $ 38.70 | $ 37.80 | |
| May 15, 2025 | -$ 15.05 | $ 36.60 | $ 35.40 |
Adagio Medical Holdings released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Adagio Medical Holdings missed analysts’ expectations during the last earnings period by
